Buphenine
Medication
- C04AA02 (WHO) G02CA02 (WHO)
- 4-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]propyl}phenol
- 447-41-6
- 4567
- 4407
- 695DKH33EI
- ChEMBL114655
Y
- DTXSID4023387
- Interactive image
- OC(c1ccc(O)cc1)C(NC(C)CCc2ccccc2)C
Buphenine (or nylidrin; trade name Arlidin) is a β2 adrenoreceptor agonist[1] that acts as a vasodilator.[2]
It was developed as a chemical derivative of oxilofrine, and first reported in the literature in 1950.[3]
See also
- Isoxsuprine
References
- ^ Mittag TW, Tormay A, Messenger M, Podos SM (February 1985). "Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin". Invest Ophthalmol Vis Sci. 26 (2): 163–9. PMID 2857689. Archived from the original on 2013-04-15.
- ^ Freedman L (1955). "Arlidin: a new vasodilative sympathomimetic drug". Angiology. 6 (1): 52–8. doi:10.1177/000331975500600106. PMID 14350296. S2CID 46317963.
- ^ Külz F, Schneider M (1950). "Über neue gefäßerweiternde Sympathomimetika" [On new vasodilative sympathomimetics]. Klin Wochenschr (in German). 28 (31–32): 535–7. doi:10.1007/BF01481535. PMID 14775050.
- v
- t
- e
Tocolytics/labor repressants (G02CA)
- Buphenine
- Fenoterol
- Hexoprenaline
- Ritodrine
- Terbutaline
| |
|---|---|
| Phenylethanolamine derivatives |
|
| Alpha blockers |
|
| Niacin and derivatives | |
| Purine derivatives | |
| Ergot alkaloids | |
| Other peripheral vasodilators | |
| |
|---|---|
| AMPARTooltip α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor |
|
| KARTooltip Kainate receptor |
|
| NMDARTooltip N-Methyl-D-aspartate receptor |
|
| |
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
